Illumina, Inc. vs Kinder Morgan Inc — how do they compare? Illumina, Inc. trades at $193.06 (market cap $28.96B), while Kinder Morgan Inc trades at $31.6 (market cap $69.90B). The key difference: Kinder Morgan Inc is far larger — about 2.4× Illumina, Inc.'s market cap, and Kinder Morgan Inc pays a 3.76% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ILMN | KMI | |
|---|---|---|
Market Cap | $28.96B | $69.90B |
Sector | Health | Energy |
52-Week High | $205.10 | $34.31 |
52-Week Low | $91.00 | $25.84 |
Enterprise Value | $30.32B | $101.95B |
Dividend Yield | — | 3.76% |
Trailing returns across standard periods
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →